SCHEMBL20178650

SCHEMBL20178650

CCN1CCc2cc(C(=O)O)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.54
NOTUM Q6P988 1/20 0.46
ALDH1A1 P00352 3/20 0.45
ALOX5 P09917 1/20 0.45
TP53 P04637 4/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
CASP1 P29466 1/20 0.44
HTT P42858 1/20 0.44
CASP7 P55210 1/20 0.44
SMAD3 P84022 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20178649 0.92 ALDH1A1 (0.52) ACHEALDH1A1TP53MAPTKDM4E
SCHEMBL4929256 0.88 ALDH1A1 (0.57) ACHEALDH1A1ALOX5TP53MAPT
SCHEMBL5404613 0.88 ACHE (0.46) ACHEALDH1A1MAPTKDM4EMEN1
SCHEMBL4934508 0.84 ACHE (0.58) ACHEALDH1A1TP53MAPTKDM4E
SCHEMBL1310717 0.83 HDAC1 (0.49) ACHEALDH1A1TP53MAPTKDM4E
SCHEMBL20178648 0.82 SRD5A1 (0.58) ACHEALDH1A1TP53MAPTKDM4E
SCHEMBL18593240 0.82 GAA (0.54) ACHEALDH1A1TP53MAPTKDM4E
SCHEMBL27611315 0.81 ACHE (0.57) ACHENOTUMALDH1A1MAPTKDM4E
SCHEMBL697874 0.81 ALOX5 (0.56) ACHEALOX5MCL1
SCHEMBL10230451 0.80 ACHE (0.45) ACHENOTUMALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2020-03-24 US disclosed
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141941-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF NR1H4, FXR1, SLC10A1 ACHE 4086/4885NOTUM 1474/4885ALDH1A1 2185/4885
US-10597391-B2 Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof NR1H4, FXR1, SLC10A1 ACHE 4086/4885NOTUM 1474/4885ALDH1A1 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.